Andrew Polson

Andrew Polson

Company: Genentech

Job title: Principal Scientist


Andrew Polson is a Principal Scientist at Genentech where he leads the development of antibody-drug conjugates and other antibody based cancer therapeutics. On these topics Andrew has over 13 corresponding author publications and is an inventor on over 15 issued patents.  Prior to his 18 years at Genentech he was a postdoctoral fellow in virology at the University of California, San Francisco.  He received his Ph.D. in biochemistry from the University of Utah. 


Live Discussion & Question Time 10:00 am

Read more

day: Day One

Polatuzumab Vedotin From Beginning to Approval & Beyond 9:00 am

• Reviewing the discovery of Polatuzumab • Evaluating early clinical data and gaining approval • Exploring future combinationsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.